Lilly Bamlanivimab Antibody Playbook

Lilly Bamlanivimab Antibody Playbook

This Antibody Playbook provides information for state, territorial and local public health programs.

This antibody playbook provides information for state, territorial and local public health programs to plan and operationalize a bamlanivimab antibody response to COVID-19. The sections of this document cover specific areas of COVID-19 antibody program planning and implementation, as well as links to resources to assist with those efforts.

Related Content

CHA Submits Comments on Long COVID RFI

Children’s Hospital Association submitted a response to Senate HELP Committee Chair Sen. Sanders’ request for information on Long COVID.

May 23, 2024

CHA Comments on Stimulant Medication Shortages

Children’s health groups are asking HHS and the DEA to convene stakeholders to identify actionable solutions about ongoing stimulant medication shortages.

May 23, 2024

Creating a Universal Standard for Lab Test Names

A multidisciplinary collaborative works to eliminate confusion, errors, and waste from the laboratory test ordering process.

March 01, 2024